Role of lymphocytes in liver cancer
Year: 2013
Type: review
Abstract: Hepatocellular carcinoma (HCC) typically occurs in patients with chronic inflammatory liver diseases, such as viral hepatitis or (non-)alcoholic steatohepatitis. Inflammation appears indeed as a crucial factor in hepatocarcinogenesis. Nevertheless, sophisticated animal models and studies of human samples revealed that the HCC also elicits antitumor immune responses. Patrolling and infiltrating lymphocytes (e.g., NKT and T cells, respectively) can exert decisive functions in the transition from chronic hepatic inflammation to cancer as well as in antitumor immune responses. An improved understanding of the cellular and molecular mechanisms whereby inflammation promotes or restricts hepatocarcinogenesis will open new avenues for therapeutic approaches to liver cancer.
Source: OncoImmunology
DOI: 10.4161/onci.26468
Authors: Jana C Mossanen, Frank Tacke
Institutions: Universitätsklinikum Aachen, RWTH Aachen University
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,913
Funder: Deutsche Forschungsgemeinschaft
Awards: G1392329581, G3196656373, G5264470636
OpenAlex ID: W1975949711
